1.Avram SI, Crisan L, Pacureanu LM, Bora A, Seclaman E, Balint M, Kurunczi LG. (2013) Challenges in docking 2-hydroxy and 2,4-dihydroxychalcones into the binding site of ALR2, 22 (8):[10.1007/s00044-012-0367-5]
2.Ahmad I, Thakur JP, Chanda D, Saikia D, Khan F, Dixit S, Kumar A, Konwar R, Negi AS, Gupta A.. (2013) Syntheses of lipophilic chalcones and their conformationally restricted analogues as antitubercular agents., 23 (5):[PMID:23369537][10.1016/j.bmcl.2012.12.096]
3.Quaglio D, Zhdanovskaya N, Tobajas G, Cuartas V, Balducci S, Christodoulou MS, Fabrizi G, Gargantilla M, Priego EM, Carmona Pestaña Á, Passarella D, Screpanti I, Botta B, Palermo R, Mori M, Ghirga F, Pérez-Pérez MJ.. (2019) Chalcones and Chalcone-mimetic Derivatives as Notch Inhibitors in a Model of T-cell Acute Lymphoblastic Leukemia., 10 (4):[PMID:30996810][10.1021/acsmedchemlett.8b00608]